NCT02377232

Brief Summary

Several screening methods exist to screen patients for CRC ranging from invasive (i.e., colonoscopy) to less invasive (i.e., testing the stool for blood). Although choice between screening methods is recommended, patients are not currently offered an unbiased choice and physicians generally recommend only colonoscopy. In this project, the investigators will answer the following questions: 1) Is it feasible to incorporate a DA in the AHP protocol?; 2) Is it feasible to incorporate mailing patients a stool blood test?; 3) Does the DA change CRC screening decision quality, using proxy measures such as knowledge and intent; and 4) Does the DA change the proportion of participants that complete a CRC screening test? To answer these questions the investigators will compare survey responses and CRC test type completed between two AHP CRC surveillance patients groups - those that received usual care versus those that received the DA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
424

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 3, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

June 26, 2017

Status Verified

June 1, 2017

Enrollment Period

1.2 years

First QC Date

February 25, 2015

Last Update Submit

June 22, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Colon Cancer Screening Intent

    Measured using a survey instrument to assess intent

    6 months

Secondary Outcomes (1)

  • Colon Cancer Screening Completed

    6 Months

Study Arms (2)

Usual Care Outreach for Colon Cancer Screening

ACTIVE COMPARATOR

Receives standard of care outreach concerning colon cancer screening.

Behavioral: Usual Care Outreach for Colon Cancer Screening

Decision Aid for Colon Cancer Screening

ACTIVE COMPARATOR

Receives colon cancer screening decision aid intervention in addition to outreach.

Behavioral: Decision Aid for Colon Cancer Screening

Interventions

Paper decision aid describing different screening options for colon cancer

Decision Aid for Colon Cancer Screening

Patients overdue for colon cancer screening are contacted and outreach is performed in an effort to schedule colonoscopy

Usual Care Outreach for Colon Cancer Screening

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals that fall within the age range for CRC screening surveillance (age 50 to \< = 75 years) from AHP
  • Are eligible for CRC screening surveillance from AHP
  • Were seen in the last 18 months by a provider at one of the primary medical care clinics from the University of Colorado General Internal Medicine, Family Medicine, or the Women's Integrated Services in Health clinic, and the individual's primary medical care provider has provided approval for AHP CRC outreach to an AHP staff person
  • Have no record of a colonoscopy within the last 10 years,
  • Have no record of flexible sigmoidoscopy or double-contrast barium enema within the past 5 years, or
  • Have no record of FOBT within the past year.

You may not qualify if:

  • Individuals that do not speak English
  • Individuals that have limited cognitive function/developmental disabilities
  • Individuals that have a personal or family history of CRC (previous adenomatous polyp), and/or, have a signs and symptoms colonoscopy order from their primary care physician
  • Not eligible for CRC screening surveillance from AHP
  • Have a terminal medical illness that would otherwise categorize them as inappropriate candidates for CRC screening as noted in their EPIC EMR:
  • The individual exhibits any of the following:

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Anschutz Medical Campus

Aurora, Colorado, 80045, United States

Location

MeSH Terms

Conditions

Colonic Neoplasms

Interventions

Decision Support Techniques

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Carmen L Lewis, MD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2015

First Posted

March 3, 2015

Study Start

May 1, 2015

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

June 26, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

Locations